Quick Answer
Acurx Pharmaceuticals, Inc. reported Total Assets of $7.69 million for the year ending 2025.
- Acurx Pharmaceuticals, Inc. showed an increase of +99.3% in Total Assets from 2024 to 2025.
- This data is from Acurx Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $17.44 million | Q3 2021: $14.99 million | Q1 2022: $11.32 million | Q2 2022: $9.26 million | Q1 2024: $9.11 million | Q2 2024: $6.58 million | Q3 2025: $6.11 million.
- Over the full 6 years of available data (2020 to 2025), Acurx Pharmaceuticals, Inc.'s Total Assets has grown by 138.5%.
- Historical annual values: Fiscal year 2025: $7.69 million | Fiscal year 2024: $3.86 million | Fiscal year 2023: $7.71 million | Fiscal year 2022: $9.38 million | Fiscal year 2021: $13.25 million | Fiscal year 2020: $3.22 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: